Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.

Jeanna Parsons Leigh, Stephana J Moss, Trenton M White, Camila A Picchio, Kenneth H Rabin, Scott C Ratzan, Katarzyna Wyka, Ayman El-Mohandes, Jeffrey V Lazarus
Author Information
  1. Jeanna Parsons Leigh: School of Health Administration, Faculty of Health, Dalhousie University, Halifax, Canada.
  2. Stephana J Moss: School of Health Administration, Faculty of Health, Dalhousie University, Halifax, Canada.
  3. Trenton M White: Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  4. Camila A Picchio: Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  5. Kenneth H Rabin: Graduate School of Public Health & Health Policy, City University of New York (CUNY), New York City, United States.
  6. Scott C Ratzan: Graduate School of Public Health & Health Policy, City University of New York (CUNY), New York City, United States.
  7. Katarzyna Wyka: Graduate School of Public Health & Health Policy, City University of New York (CUNY), New York City, United States.
  8. Ayman El-Mohandes: Graduate School of Public Health & Health Policy, City University of New York (CUNY), New York City, United States.
  9. Jeffrey V Lazarus: Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain; Faculty of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: jeffrey.lazarus@isglobal.org.

Abstract

BACKGROUND: Several early COVID-19 studies aimed to assess the potential acceptance of a vaccine among healthcare providers, but relatively few studies of this population have been published since the vaccines became widely available. Vaccine safety, speed of development, and low perceived disease risk were commonly cited as factors for COVID-19 vaccine hesitancy among this group.
PURPOSE AND METHODS: In a secondary analysis based on a cross-sectional, structured survey, the authors aimed to assess the associations between self-reported vaccine hesitancy and a number of sociodemographic and COVID-19 vaccine perception factors using data from 3,295 healthcare providers (physicians, nurses, community health workers, other healthcare providers) in 23 countries.
FINDINGS: 494 (15.0%) of the participants reported vaccine hesitancy, of whom 132 (4.0%) would outright refuse to accept a COVID-19 vaccine. Physicians were the least hesitant. Vaccine hesitancy was more likely to occur among those with less than the median income and, to a lesser degree, younger age. Safety and risk concerns and lack of trust that vaccines would be equitably distributed were strongly associated with hesitancy, less so were concerns about the efficacy of COVID-19 vaccines.
INTERPRETATION: Findings suggest a need to address safety and risk concerns through tailored messaging, training, and/or incentive approaches among healthcare providers, as well as the need for international and national vaccination efforts to ensure equitable distribution.

Keywords

References

  1. J Affect Disord. 2020 Mar 15;265:395-401 [PMID: 32090765]
  2. Ann Intern Med. 2021 Apr;174(4):484-492 [PMID: 33347320]
  3. Vaccine. 2015 Aug 14;33(34):4180-90 [PMID: 25896377]
  4. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  5. Euro Surveill. 2021 Jan;26(3): [PMID: 33478623]
  6. Infect Control Hosp Epidemiol. 2022 Oct;43(10):1424-1432 [PMID: 34538290]
  7. Vaccines (Basel). 2021 Jun 25;9(7): [PMID: 34202298]
  8. Curr Opin Immunol. 2021 Aug;71:62-68 [PMID: 34118728]
  9. Acad Emerg Med. 2021 Apr;28(4):455-458 [PMID: 33608937]
  10. Vaccines (Basel). 2021 Jun 17;9(6): [PMID: 34204379]
  11. Lancet Public Health. 2022 Jan;7(1):e15-e22 [PMID: 34914925]
  12. Eur J Epidemiol. 2020 Aug;35(8):775-779 [PMID: 32785815]
  13. Vaccine. 2011 Sep 2;29(38):6472-84 [PMID: 21756960]
  14. Vaccine. 2016 Sep 22;34(41):5013-5020 [PMID: 27576074]
  15. J R Soc Med. 2021 Jun;114(6):295-298 [PMID: 34077688]
  16. Vaccine. 2020 Oct 21;38(45):7049-7056 [PMID: 32980199]
  17. Health Aff (Millwood). 2018 Feb;37(2):183-190 [PMID: 29401011]
  18. Clin Infect Dis. 2021 Nov 16;73(10):1776-1783 [PMID: 33491049]
  19. J Occup Environ Med. 2021 Oct 1;63(10):852-856 [PMID: 34138823]
  20. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  21. Int J Nurs Stud. 2021 Feb;114:103854 [PMID: 33326864]
  22. Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609 [PMID: 29617183]
  23. Am J Infect Control. 2021 Oct;49(10):1295-1304 [PMID: 34273461]
  24. Implement Sci. 2008 Jul 16;3:36 [PMID: 18631386]
  25. Vaccine. 2016 Dec 20;34(52):6700-6706 [PMID: 27810314]
  26. J Community Health. 2021 Dec;46(6):1244-1251 [PMID: 33877534]
  27. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  28. Am J Infect Control. 2021 Sep;49(9):1152-1157 [PMID: 33930516]
  29. Vaccines (Basel). 2021 May 02;9(5): [PMID: 34063313]
  30. Psychol Health. 2021 Dec;36(12):1461-1479 [PMID: 33297739]
  31. Psychol Sci Public Interest. 2017 Dec;18(3):149-207 [PMID: 29611455]
  32. PLoS One. 2020 Oct 6;15(10):e0240011 [PMID: 33022023]
  33. J Hosp Infect. 2021 Feb;108:168-173 [PMID: 33259883]
  34. Hum Vaccin Immunother. 2013 Aug;9(8):1763-73 [PMID: 23584253]
  35. Public Health. 2021 May;194:245-251 [PMID: 33965796]

MeSH Term

COVID-19
COVID-19 Vaccines
Cross-Sectional Studies
Health Knowledge, Attitudes, Practice
Health Personnel
Humans
Vaccination
Vaccination Hesitancy
Vaccines

Chemicals

COVID-19 Vaccines
Vaccines

Word Cloud

Created with Highcharts 10.0.0COVID-19vaccinehesitancyamonghealthcareprovidersvaccinesVaccineriskconcernsstudiesaimedassesssafetyfactorshealth23countries0%lessneedBACKGROUND:SeveralearlypotentialacceptancerelativelypopulationpublishedsincebecamewidelyavailablespeeddevelopmentlowperceiveddiseasecommonlycitedgroupPURPOSEANDMETHODS:secondaryanalysisbasedcross-sectionalstructuredsurveyauthorsassociationsself-reportednumbersociodemographicperceptionusingdata3295physiciansnursescommunityworkersFINDINGS:49415participantsreported1324outrightrefuseacceptPhysiciansleasthesitantlikelyoccurmedianincomelesserdegreeyoungerageSafetylacktrustequitablydistributedstronglyassociatedefficacyINTERPRETATION:Findingssuggestaddresstailoredmessagingtrainingand/orincentiveapproacheswellinternationalnationalvaccinationeffortsensureequitabledistributionFactorsaffectingGlobalHealthcareproviderSARS-CoV-2Vaccination

Similar Articles

Cited By